The DOI matches its Crossref record; 64 of the 64 references it cites were found in a registry or an index.
RNA Binding Antagonizes Neurotoxic Phase Transitions of TDP-43
Open accessAbstract
Summary TDP-43 proteinopathy is a pathological hallmark of ALS/FTD where cytoplasmic TDP-43 inclusions are observed within degenerating regions of patient postmortem tissue. The mechanism by which TDP-43 aggregates has remained elusive due to technological limitations which prevent the analysis of specific TDP-43 interactions in live cells. We present an optogenetic approach to reliably induce TDP-43 proteinopathy under spatiotemporal control. We show that the formation of pathologically-relevant inclusions is driven by aberrant interactions between low-complexity domains of TDP-43 that are antagonized by RNA-binding. While stress granules are hypothesized to be a conduit for seeding TDP-43 proteinopathy, we demonstrate pathological inclusions outside these RNA-rich structures. Furthermore, we show that aberrant phase transitions of cytoplasmic TDP-43 are neurotoxic and treatment with oligonucleotides composed of TDP-43 target sequences prevent inclusions and rescue neurotoxicity. Collectively, these studies provide insight into the mechanisms that underlie TDP-43 proteinopathy and present a potential avenue for therapeutic intervention.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis
Neumann, M., Sampathu, D. M., Kwong, L. K., Truax, A. C., Micsenyi, M. C., Chou, T. T., Bruce, J., Schuck, T., Grossman, M., Clark, C. M., et al. (2006) · Science · doi:10.1126/science.1134108 · Cited by 6,576
Liquid phase condensation in cell physiology and disease
Shin, Y., & Brangwynne, C. P. (2017) · Science · doi:10.1126/science.aaf4382 · Cited by 4,152
Germline P Granules Are Liquid Droplets That Localize by Controlled Dissolution/Condensation
Brangwynne, C. P., Eckmann, C. R., Courson, D. S., Rybarska, A., Hoege, C., Gharakhani, J., Jülicher, F., & Hyman, A. A. (2009) · Science · doi:10.1126/science.1172046 · Cited by 3,202
Molliex, A., Temirov, J., Lee, J., Coughlin, M., Kanagaraj, A. P., Kim, H. J., Mittag, T., & Taylor, J. P. (2015) · Cell · doi:10.1016/j.cell.2015.09.015 · Cited by 2,893
Converging Mechanisms in ALS and FTD: Disrupted RNA and Protein Homeostasis
Ling, S.-C., Polymenidou, M., & Cleveland, D. W. (2013) · Neuron · doi:10.1016/j.neuron.2013.07.033 · Cited by 1,811 · cited 21×
“No effective treatments currently exist to halt ALS or FTD progression, and the cause(s) of these disorders remain unknown.”
InfluentialNott, T. J., Petsalaki, E., Farber, P., Jervis, D., Fussner, E., Plochowietz, A., Craggs, T. D., Bazett-Jones, D. P., Pawson, T., Forman-Kay, J. D., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.01.013 · Cited by 1,803
Polymer physics of intracellular phase transitions
Brangwynne, C. P., Tompa, P., & Pappu, R. V. (2015) · Nature Physics · doi:10.1038/nphys3532 · Cited by 1,553
Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS
Elden, A. C., Kim, H.-J., Hart, M. P., Chen-Plotkin, A. S., Johnson, B. S., Fang, X., Armakola, M., Geser, F., Greene, R., Lu, M. M., et al. (2010) · Nature · doi:10.1038/nature09320 · Cited by 1,325
Elbaum-Garfinkle, S., Kim, Y., Szczepaniak, K., Chen, C. C.-H., Eckmann, C. R., Myong, S., & Brangwynne, C. P. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1504822112 · Cited by 1,278
Rapid blue-light–mediated induction of protein interactions in living cells
Kennedy, M. J., Hughes, R. M., Peteya, L. A., Schwartz, J. W., Ehlers, M. D., & Tucker, C. L. (2010) · Nature Methods · doi:10.1038/nmeth.1524 · Cited by 1,120
Stress granules: the Tao of RNA triage
Anderson, P., & Kedersha, N. (2008) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2007.12.003 · Cited by 1,116
RNA buffers the phase separation behavior of prion-like RNA binding proteins
Maharana, S., Wang, J., Papadopoulos, D. K., Richter, D., Pozniakovsky, A., Poser, I., Bickle, M., Rizk, S., Guillén-Boixet, J., Franzmann, T. M., et al. (2018) · Science · doi:10.1126/science.aar7366 · Cited by 1,106
The C9orf72 repeat expansion disrupts nucleocytoplasmic transport.
Zhang, K., Donnelly, C. J., Haeusler, A. R., Grima, J. C., Machamer, J. B., Steinwald, P., Daley, E. L., Miller, S. J., Cunningham, K. M., Vidensky, S., et al. (2015) · Nature · doi:10.1038/nature14973 · Cited by 982
Self-citationSpatiotemporal Control of Intracellular Phase Transitions Using Light-Activated optoDroplets
Shin, Y., Berry, J., Pannucci, N., Haataja, M. P., Toettcher, J. E., & Brangwynne, C. P. (2017) · Cell · doi:10.1016/j.cell.2016.11.054 · Cited by 965
Conicella, A. E., Zerze, G. H., Mittal, J., & Fawzi, N. L. (2016) · Structure · doi:10.1016/j.str.2016.07.007 · Cited by 857
GGGGCC repeat expansion in C9orf72 compromises nucleocytoplasmic transport
Freibaum, B. D., Lu, Y., Lopez-Gonzalez, R., Kim, N. C., Almeida, S., Lee, K.-H., Badders, N., Valentine, M., Miller, B. L., Wong, P. C., et al. (2015) · Nature · doi:10.1038/nature14974 · Cited by 841
Johnson, B. S., Snead, D., Lee, J. J., McCaffery, J. M., Shorter, J., & Gitler, A. D. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.010264 · Cited by 782
Self-citationExporting RNA from the nucleus to the cytoplasm
Köhler, A., & Hurt, E. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2255 · Cited by 775
RNA Controls PolyQ Protein Phase Transitions
Zhang, H., Elbaum-Garfinkle, S., Langdon, E. M., Taylor, N., Occhipinti, P., Bridges, A. A., Brangwynne, C. P., & Gladfelter, A. S. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.09.017 · Cited by 709
Buratti, E., & Baralle, F. E. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m104236200 · Cited by 700
TDP-43 proteinopathy and motor neuron disease in chronic traumatic encephalopathy
McKee, A. C., Gavett, B. E., Stern, R. A., Nowinski, C. J., Cantu, R. C., Kowall, N. W., Perl, D. P., Hedley-Whyte, E. T., Price, B., Sullivan, C., et al. (2010) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181ee7d85 · Cited by 659
TDP‐43 regulates its mRNA levels through a negative feedback loop
Ayala, Y. M., De Conti, L., Avendaño‐Vázquez, S. E., Dhir, A., Romano, M., D'Ambrogio, A., Tollervey, J., Ule, J., Baralle, M., Buratti, E., et al. (2011) · The EMBO Journal · doi:10.1038/emboj.2010.310 · Cited by 637
Aberrant cleavage of TDP-43 enhances aggregation and cellular toxicity
Zhang, Y.-J., Xu, Y.-F., Cook, C., Gendron, T. F., Roettges, P., Link, C. D., Lin, W.-L., Tong, J., Castanedes-Casey, M., Ash, P., et al. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0900688106 · Cited by 604
Therapeutic reduction of ataxin-2 extends lifespan and reduces pathology in TDP-43 mice
Becker, L. A., Huang, B., Bieri, G., Ma, R., Knowles, D. A., Jafar-Nejad, P., Messing, J., Kim, H. J., Soriano, A., Auburger, G., et al. (2017) · Nature · doi:10.1038/nature22038 · Cited by 571
Natively Unfolded Nucleoporins Gate Protein Diffusion across the Nuclear Pore Complex
Patel, S. S., Belmont, B. J., Sante, J. M., & Rexach, M. F. (2007) · Cell · doi:10.1016/j.cell.2007.01.044 · Cited by 566
TDP‐43 is recruited to stress granules in conditions of oxidative insult
Colombrita, C., Zennaro, E., Fallini, C., Weber, M., Sommacal, A., Buratti, E., Silani, V., & Ratti, A. (2009) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2009.06383.x · Cited by 539
Arnold, E. S., Ling, S.-C., Huelga, S. C., Lagier-Tourenne, C., Polymenidou, M., Ditsworth, D., Kordasiewicz, H. B., McAlonis-Downes, M., Platoshyn, O., Parone, P. A., et al. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1222809110 · Cited by 492
Al-Sarraj, S., King, A., Troakes, C., Smith, B., Maekawa, S., Bodi, I., Rogelj, B., Al-Chalabi, A., Hortobágyi, T., & Shaw, C. E. (2011) · Acta Neuropathologica · doi:10.1007/s00401-011-0911-2 · Cited by 475
Guo, L., Kim, H. J., Wang, H., Monaghan, J., Freyermuth, F., Sung, J. C., O’Donovan, K., Fare, C. M., Diaz, Z., Singh, N., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.002 · Cited by 466
Self-citationA single N‐terminal phosphomimic disrupts TDP‐43 polymerization, phase separation, and RNA splicing
Wang, A., Conicella, A. E., Schmidt, H. B., Martin, E. W., Rhoads, S. N., Reeb, A. N., Nourse, A., Ramirez Montero, D., Ryan, V. H., Rohatgi, R., et al. (2018) · The EMBO Journal · doi:10.15252/embj.201797452 · Cited by 444
RNA-binding proteins with prion-like domains in health and disease
Harrison, A. F., & Shorter, J. (2017) · Biochemical Journal · doi:10.1042/bcj20160499 · Cited by 422
Self-citationInduced fit in RNA-protein recognition.
Williamson, J. R. (2000) · Nature Structural Biology · doi:10.1038/79575 · Cited by 421
McGurk, L., Gomes, E., Guo, L., Mojsilovic-Petrovic, J., Tran, V., Kalb, R. G., Shorter, J., & Bonini, N. M. (2018) · Molecular Cell · doi:10.1016/j.molcel.2018.07.002 · Cited by 409
Self-citationAn optimized optogenetic clustering tool for probing protein interaction and function
Taslimi, A., Vrana, J. D., Chen, D., Borinskaya, S., Mayer, B. J., Kennedy, M. J., & Tucker, C. L. (2014) · Nature Communications · doi:10.1038/ncomms5925 · Cited by 386
TDP-43 Proteinopathy and ALS: Insights into Disease Mechanisms and Therapeutic Targets
Scotter, E. L., Chen, H.-J., & Shaw, C. E. (2015) · Neurotherapeutics · doi:10.1007/s13311-015-0338-x · Cited by 382
Kim, H.-J., Raphael, A. R., LaDow, E. S., McGurk, L., Weber, R. A., Trojanowski, J. Q., Lee, V. M.-Y., Finkbeiner, S., Gitler, A. D., & Bonini, N. M. (2014) · Nature Genetics · doi:10.1038/ng.2853 · Cited by 379
Afroz, T., Hock, E.-M., Ernst, P., Foglieni, C., Jambeau, M., Gilhespy, L. A. B., Laferriere, F., Maniecka, Z., Plückthun, A., Mittl, P., et al. (2017) · Nature Communications · doi:10.1038/s41467-017-00062-0 · Cited by 349
Dipeptide repeat protein pathology in C9ORF72 mutation cases: clinico-pathological correlations
Mackenzie, I. R., Arzberger, T., Kremmer, E., Troost, D., Lorenzl, S., Mori, K., Weng, S.-M., Haass, C., Kretzschmar, H. A., Edbauer, D., et al. (2013) · Acta Neuropathologica · doi:10.1007/s00401-013-1181-y · Cited by 345
Structural insights into TDP-43 in nucleic-acid binding and domain interactions
Kuo, P.-H., Doudeva, L. G., Wang, Y.-T., Shen, C.-K. J., & Yuan, H. S. (2009) · Nucleic Acids Research · doi:10.1093/nar/gkp013 · Cited by 330
Nuclear Import Receptor Inhibits Phase Separation of FUS through Binding to Multiple Sites
Yoshizawa, T., Ali, R., Jiou, J., Fung, H. Y. J., Burke, K. A., Kim, S. J., Lin, Y., Peeples, W. B., Saltzberg, D., Soniat, M., et al. (2018) · Cell · doi:10.1016/j.cell.2018.03.003 · Cited by 329
Donato, R., Miljan, E. A., Hines, S. J., Aouabdi, S., Pollock, K., Patel, S., Edwards, F. A., & Sinden, J. D. (2007) · BMC Neuroscience · doi:10.1186/1471-2202-8-36 · Cited by 308
ALS Genes in the Genomic Era and their Implications for FTD
Nguyen, H. P., Van Broeckhoven, C., & van der Zee, J. (2018) · Trends in Genetics · doi:10.1016/j.tig.2018.03.001 · Cited by 307
Rodent Models of Amyotrophic Lateral Sclerosis
Philips, T., & Rothstein, J. D. (2015) · Current Protocols in Pharmacology · doi:10.1002/0471141755.ph0567s69 · Cited by 294
Bentmann, E., Neumann, M., Tahirovic, S., Rodde, R., Dormann, D., & Haass, C. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.328757 · Cited by 275
Gopal, P. P., Nirschl, J. J., Klinman, E., & Holzbaur, E. L. F. (2017) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1614462114 · Cited by 261
Neumann, M., Kwong, L. K., Truax, A. C., Vanmassenhove, B., Kretzschmar, H. A., Van Deerlin, V. M., Clark, C. M., Grossman, M., Miller, B. L., Trojanowski, J. Q., et al. (2007) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/01.jnen.0000248554.45456.58 · Cited by 237
Daigle, J. G., Lanson, N. A., Smith, R. B., Casci, I., Maltare, A., Monaghan, J., Nichols, C. D., Kryndushkin, D., Shewmaker, F., & Pandey, U. B. (2013) · Human Molecular Genetics · doi:10.1093/hmg/dds526 · Cited by 206
Self-citationIn Vivo Formation of Vacuolated Multi-phase Compartments Lacking Membranes
Schmidt, H. B., & Rohatgi, R. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.088 · Cited by 178
Pathological mechanisms underlying TDP-43 driven neurodegeneration in FTLD-ALS spectrum disorders
Janssens, J., & Broeckhoven, C. V. (2013) · Human Molecular Genetics · doi:10.1093/hmg/ddt349 · Cited by 151
The N-terminus of TDP-43 promotes its oligomerization and enhances DNA binding affinity
Chang, C., Wu, T.-H., Wu, C.-Y., Chiang, M.-H., Toh, E. K.-W., Hsu, Y.-C., Lin, K.-F., Liao, Y.-H., Huang, T.-H., & Huang, J. J. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.07.071 · Cited by 150
Cytoplasmic accumulation and aggregation of TDP-43 upon proteasome inhibition in cultured neurons.
van Eersel, J., Ke, Y. D., Gladbach, A., Bi, M., Götz, J., Kril, J. J., & Ittner, L. M. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022850 · Cited by 130
Characterizing TDP-43 interaction with its RNA targets
Bhardwaj, A., Myers, M. P., Buratti, E., & Baralle, F. E. (2013) · Nucleic Acids Research · doi:10.1093/nar/gkt189 · Cited by 130
Inside out: the role of nucleocytoplasmic transport in ALS and FTLD
Boeynaems, S., Bogaert, E., Damme, P. V., & Bosch, L. V. D. (2016) · Acta Neuropathologica · doi:10.1007/s00401-016-1586-5 · Cited by 129
Atomic-level evidence for packing and positional amyloid polymorphism by segment from TDP-43 RRM2
Guenther, E. L., Ge, P., Trinh, H., Sawaya, M. R., Cascio, D., Boyer, D. R., Gonen, T., Zhou, Z. H., & Eisenberg, D. S. (2018) · Nature Structural & Molecular Biology · doi:10.1038/s41594-018-0045-5 · Cited by 124
Baloh, R. H. (2011) · FEBS Journal · doi:10.1111/j.1742-4658.2011.08256.x · Cited by 122
Sun, Y., & Chakrabartty, A. (2017) · Biochemistry · doi:10.1021/acs.biochem.6b01088 · Cited by 106
Mompeán, M., Romano, V. C., Pantoja‐Uceda, D., Stuani, C., Baralle, F. E., Buratti, E., & Laurents, D. V. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.775965 · Cited by 98
Malik, A. M., Miguez, R. A., Li, X., Ho, Y.-S., Feldman, E. L., & Barmada, S. J. (2018) · eLife · doi:10.7554/elife.35977 · Cited by 92
Kitamura, A., Nakayama, Y., Shibasaki, A., Taki, A., Yuno, S., Takeda, K., Yahara, M., Tanabe, N., & Kinjo, M. (2016) · Scientific Reports · doi:10.1038/srep19230 · Cited by 79
Mihevc, S. P., Baralle, M., Buratti, E., & Rogelj, B. (2016) · Scientific Reports · doi:10.1038/srep33996 · Cited by 67
Binding of TDP-43 to the 3′UTR of Its Cognate mRNA Enhances Its Solubility
Sun, Y., Arslan, P. E., Won, A. M., Yip, C. M., & Chakrabartty, A. (2014) · Biochemistry · doi:10.1021/bi500617x · Cited by 57
Stress Granules and ALS: A Case of Causation or Correlation?
Fernandes, N., Eshleman, N., & Buchan, J. R. (2018) · Advances in neurobiology · doi:10.1007/978-3-319-89689-2_7 · Cited by 57
TDP-43—The key to understanding amyotrophic lateral sclerosis
Xu, Z., & Yang, C. (2014) · Rare Diseases · doi:10.4161/21675511.2014.944443 · Cited by 37
TDP-43: A new player on the AD field?
Youmans, K. L., & Wolozin, B. L. (2012) · Experimental Neurology · doi:10.1016/j.expneurol.2012.05.018 · Cited by 28
Cited by
Biomolecular condensates at the nexus of cellular stress, protein aggregation disease and ageing
Alberti, S., & Hyman, A. A. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-00326-6 · Cited by 1,160
The nucleolus as a multiphase liquid condensate
Lafontaine, D. L. J., Riback, J. A., Bascetin, R., & Brangwynne, C. P. (2021) · Nature Reviews Molecular Cell Biology · doi:10.1038/s41580-020-0272-6 · Cited by 1,051
Stress granules and neurodegeneration
Wolozin, B., & Ivanov, P. (2019) · Nature Reviews Neuroscience · doi:10.1038/s41583-019-0222-5 · Cited by 810
Phase separation and neurodegenerative diseases: a disturbance in the force
Zbinden, A., Pérez-Berlanga, M., De Rossi, P., & Polymenidou, M. (2020) · Developmental Cell · doi:10.1016/j.devcel.2020.09.014 · Cited by 500
The role of TDP-43 mislocalization in amyotrophic lateral sclerosis
Suk, T. R., & Rousseaux, M. W. C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00397-1 · Cited by 450
Metadata
- Authors
- Mann, J. R., Gleixner, A. M., Mauna, J. C., Gomes, E., DeChellis-Marks, M. R., Needham, P. G., Copley, K. E., Hurtle, B., Portz, B., Pyles, N. J., Guo, L., Calder, C. B., Wills, Z. P., Pandey, U. B., Kofler, J. K., Brodsky, J. L., Thathiah, A., Shorter, J., & Donnelly, C. J.
- Venue
- Neuron
- Publisher
- Elsevier BV
- Published
- 2019-04
- Volume
- 102
- Issue
- 2
- Pages
- 321-338.e8
- ISSN
- 0896-6273 (ISSN-L)
- OpenAlex
- W2917988060
- Cited by
- 537
- References
- 64
- FWCI
- 37.86
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.